https://share.google/OfLzb9jqQywV1ZxOt

> While European health authorities aren’t instituting bans on treatment, currently minors in six European countries—Norway, U.K. Sweden, Denmark, France and Finland—can access puberty blockers and cross-sex hormones only if they meet strict eligibility requirements, usually in the context of a tightly controlled research setting. (Italics in the original)

Read through your quotes carefully:

> The Council for Choices in Health Care allows the use of puberty blockers in transgender children after a case-by-case assessment if there are no medical contraindications.

And how many of such cases were granted? This could be a de facto ban, if no such cases are granted.

> issued a non-binding report finding "there is insufficient evidence for the use of puberty blockers and cross sex hormone treatments in young people" and recommending changing to a cautious approach.

Again, how many new patients are being put on blockers after this recommendation?

You're trying to spin this false narrative that patients with gender dysphoria are still being prescribed puberty blockers as normal treatment for GD. This is not the case. Even though the legislatures in these countries haven't banned the treatment, effectively nobody is getting puberty blockers for childhood GD in these countries.

Actions speak louder than words. You can split hairs about how "recommending" the discontinuation of puberty blocks is not ban. But at the end of the day, what unambiguously true is that the vast majority of patients who are prescribed blockers in the US would not be prescribed blockers in these countries. If you have actual stats on the number of new patients prescribed blockers in these countries in 2025, by all means share it.